Voltage-gated sodium channel protein family (VGSC)

Voltage-gated sodium channel protein family (VGSC/NaV) consists of transmembrane proteins responsible for initiating and propagating action potentials in excitable cells such as neurons, muscle, and some endocrine cells[1][2][5]. Each channel is formed by a large alpha subunit—which creates a voltage-gated pore selective for sodium ions—and accessory beta subunits that modulate gating kinetics and membrane localization[1][4][6]. The alpha subunit contains four homologous domains (I-IV), each with six transmembrane segments (S1-S6), where S4 acts as the voltage sensor[1][2]. The channels open in response to membrane depolarization, allowing Na+ influx, then rapidly inactivate to enable refractory periods critical for high-frequency firing[1][5]. There are at least nine functionally distinct mammalian NaV channel isoforms (NaV1.1–NaV1.9), each with unique tissue distributions and physiological/pathophysiological roles[2][3]. VGSCs are key drug targets for local anesthetics, antiepileptics, antiarrhythmics, and specific pain modulators, but their pharmacological modulation carries risks such as arrhythmia and CNS depression due to their widespread role in electrical signaling[5][4]. Dysfunction or mutations in these channels are associated with a range of diseases including epilepsy, cardiovascular disorders, chronic pain, and periodic paralysis[5][2][4].

Other names

Voltage-dependent sodium channelNaV channelSodium channel proteinVoltage-sensitive sodium channel

Blockade of sodium current (inhibition of Na+ influx); Stabilization of inactivated channel state; Slowing of recovery from inactivation; Selective inhibition of specific subtypes (e.g., NaV1.7 in pain)